DE3850109D1 - 13-trans-retinsäureester. - Google Patents

13-trans-retinsäureester.

Info

Publication number
DE3850109D1
DE3850109D1 DE3850109T DE3850109T DE3850109D1 DE 3850109 D1 DE3850109 D1 DE 3850109D1 DE 3850109 T DE3850109 T DE 3850109T DE 3850109 T DE3850109 T DE 3850109T DE 3850109 D1 DE3850109 D1 DE 3850109D1
Authority
DE
Germany
Prior art keywords
trans
acid ester
retic acid
retic
acne
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE3850109T
Other languages
English (en)
Other versions
DE3850109T2 (de
Inventor
Harlie Parish
William Purcell
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Molecular Design International Inc
Original Assignee
Molecular Design International Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Molecular Design International Inc filed Critical Molecular Design International Inc
Application granted granted Critical
Publication of DE3850109D1 publication Critical patent/DE3850109D1/de
Publication of DE3850109T2 publication Critical patent/DE3850109T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C403/00—Derivatives of cyclohexane or of a cyclohexene or of cyclohexadiene, having a side-chain containing an acyclic unsaturated part of at least four carbon atoms, this part being directly attached to the cyclohexane or cyclohexene or cyclohexadiene rings, e.g. vitamin A, beta-carotene, beta-ionone
    • C07C403/20—Derivatives of cyclohexane or of a cyclohexene or of cyclohexadiene, having a side-chain containing an acyclic unsaturated part of at least four carbon atoms, this part being directly attached to the cyclohexane or cyclohexene or cyclohexadiene rings, e.g. vitamin A, beta-carotene, beta-ionone having side-chains substituted by carboxyl groups or halides, anhydrides, or (thio)esters thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/67—Vitamins
    • A61K8/671—Vitamin A; Derivatives thereof, e.g. ester of vitamin A acid, ester of retinol, retinol, retinal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/09—Geometrical isomers
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
    • C07C2601/16—Systems containing only non-condensed rings with a six-membered ring the ring being unsaturated

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Dermatology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Birds (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Cosmetics (AREA)
  • Liquid Crystal Substances (AREA)
DE3850109T 1987-06-29 1988-06-27 13-trans-retinsäureester. Expired - Fee Related DE3850109T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US07/067,536 US4885311A (en) 1987-06-29 1987-06-29 Topical transretinoids for treatment of acne and skin diseases
PCT/US1988/002141 WO1989000157A1 (en) 1987-06-29 1988-06-27 Esters of 13-trans-retinoic acid

Publications (2)

Publication Number Publication Date
DE3850109D1 true DE3850109D1 (de) 1994-07-14
DE3850109T2 DE3850109T2 (de) 1994-10-06

Family

ID=22076659

Family Applications (1)

Application Number Title Priority Date Filing Date
DE3850109T Expired - Fee Related DE3850109T2 (de) 1987-06-29 1988-06-27 13-trans-retinsäureester.

Country Status (7)

Country Link
US (1) US4885311A (de)
EP (1) EP0366713B1 (de)
JP (1) JPH03500643A (de)
AT (1) ATE106867T1 (de)
AU (1) AU607097B2 (de)
DE (1) DE3850109T2 (de)
WO (1) WO1989000157A1 (de)

Families Citing this family (90)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5124356A (en) * 1987-06-29 1992-06-23 Molecular Design International, Inc. Dermal uses of trans-retinoids for the treatment of photoaging
US4994491A (en) * 1988-12-14 1991-02-19 Molecular Design International Dermal uses of trans-retinoids for the treatment of cancer
US5049584A (en) * 1988-12-14 1991-09-17 Molecular Design International Dermal uses of cis-retinoids for the treatment of cancer
FR2644459B1 (fr) * 1989-03-16 1994-10-28 Oreal Esters retinoiques de l-cladinose, leur procede de preparation et leur utilisation en medecine humaine ou veterinaire et en cosmetique
FR2644460A1 (fr) * 1989-03-16 1990-09-21 Oreal Esters retinoiques de d-desosamine, leur procede de preparation et leur utilisation en medecine humaine ou veterinaire et en cosmetique
US5235076A (en) * 1991-05-28 1993-08-10 University Of Hawaii Azulenic retinoid compounds, compositions and methods
DK0617614T3 (da) * 1991-12-18 1998-09-28 Salk Inst For Biological Studi Midler til modulering af processer medieret af retinoide receptorer og forbindelser anvendlige dertil
US5710176A (en) * 1994-09-16 1998-01-20 Bar-Ilan University Retinoyloxy (substituted) methyl butyrates useful for the treatment of cancer and other proliferative diseases
US6071923A (en) * 1994-09-16 2000-06-06 Bar-Ilan University Retinoyloxy aryl-substituted alkylene butyrates useful for the treatment of cancer and other proliferative diseases
US6040342A (en) * 1994-09-16 2000-03-21 Bar-Ilan University Retinoyloxy (alkyl-substituted) methyl butyrates useful for the treatment of cancer and other proliferative diseases
IT1276459B1 (it) 1995-06-30 1997-10-31 Khodor Ammar Composizioni cosmetiche con proprieta' antimicotiche, efficaci contro la psoriasi e la caduta dei capelli e metodo cosmetico per la
CA2258593A1 (en) * 1996-07-02 1998-01-08 Abraham Nudelman Retinoyloxy(substituted)alkylene butyrates useful for the treatment of cancer and other proliferative diseases
US6130248A (en) * 1996-12-30 2000-10-10 Bar-Ilan University Tricarboxylic acid-containing oxyalkyl esters and uses thereof
US6043389A (en) * 1997-03-11 2000-03-28 Mor Research Applications, Ltd. Hydroxy and ether-containing oxyalkylene esters and uses thereof
US6110955A (en) * 1997-03-11 2000-08-29 Beacon Laboratories, Inc. Metabolically stabilized oxyalkylene esters and uses thereof
US6124495A (en) 1997-03-11 2000-09-26 Beacon Laboratories, Inc. Unsaturated oxyalkylene esters and uses thereof
US6110970A (en) * 1997-03-11 2000-08-29 Beacon Laboratories, Inc. Nitrogen-containing oxyalkylene esters and uses thereof
US5939455A (en) * 1997-03-11 1999-08-17 Beacon Laboratories, Inc. Therapeutic augmentation of oxyalkylene diesters and butyric acid derivatives
US6030961A (en) * 1997-03-11 2000-02-29 Bar-Ilan Research & Development Co., Ltd. Oxyalkylene phosphate compounds and uses thereof
WO2002062335A2 (en) 2001-01-16 2002-08-15 Vascular Therapies, Llc Implantable device containing resorbable matrix material and anti-proliferative drugs for preventing or treating failure of hemodialysis vascular access and other vascular grafts
US20020182237A1 (en) 2001-03-22 2002-12-05 The Procter & Gamble Company Skin care compositions containing a sugar amine
US7235249B2 (en) 2002-03-28 2007-06-26 The Procter & Gamble Company Methods for regulating the condition of mammalian keratinous tissue via topical application of vitamin B6 compositions
US7098189B2 (en) * 2002-12-16 2006-08-29 Kimberly-Clark Worldwide, Inc. Wound and skin care compositions
JP2005020400A (ja) * 2003-06-26 2005-01-20 Hitachi Communication Technologies Ltd 無線基地局、無線通信システム、無線基地局の通信制御方法、および、無線通信網の構築方法
EP1585723A2 (de) 2003-01-17 2005-10-19 Wisconsin Alumni Research Foundation Abgewandelte retinoidverbindungen und deren verwendung
US7126017B2 (en) * 2003-01-17 2006-10-24 Wisconsin Alumni Research Foundation Method of reducing toxicity of retinoids
US20040175347A1 (en) 2003-03-04 2004-09-09 The Procter & Gamble Company Regulation of mammalian keratinous tissue using hexamidine compositions
FR2854897B1 (fr) * 2003-05-12 2007-05-04 Sederma Sa Compositions cosmetiques ou dermopharmaceutiques pour reduire les signes du vieillissement cutane.
WO2005009342A2 (en) * 2003-07-16 2005-02-03 Pharmacia Corporation Method for the treatment or prevention of dermatological disorders with a cyclooxygenase-2 inhibitor alone and in combination with a dermatological treatment agent and compositions therewith
US7485666B2 (en) * 2004-06-17 2009-02-03 Kimberly-Clark Worldwide, Inc. Vaginal health products
FR2880802B1 (fr) * 2005-01-14 2008-12-19 Sederma Soc Par Actions Simpli Composition cosmetique ou dermopharmaceutique contenant un extrait d'euglene
US20070020220A1 (en) 2005-04-27 2007-01-25 Procter & Gamble Personal care compositions
US20080095732A1 (en) * 2005-04-27 2008-04-24 Rosemarie Osborne Personal care compositions
US9616011B2 (en) 2005-04-27 2017-04-11 The Procter & Gamble Company Personal care compositions
FR2885522B1 (fr) * 2005-05-13 2020-01-10 Sederma Composition cosmetique ou dermopharmaceutique contenant de la teprenone
FR2890310B1 (fr) * 2005-09-06 2009-04-03 Sederma Soc Par Actions Simpli Utilisation des protoberberines comme agents regulant l'activite de l'unite pilosebacee
AU2006299421B2 (en) 2005-10-03 2013-01-31 Mark A. Pinsky Compositions and methods for improved skin care
US20070202061A1 (en) * 2005-10-31 2007-08-30 Naturalnano, Inc. Cosmetic skincare applications employing mineral-derived tubules for controlled release
US8404648B2 (en) * 2006-02-16 2013-03-26 Sederma Polypeptides KXK and their use
FR2900573B1 (fr) 2006-05-05 2014-05-16 Sederma Sa Nouvelles compositions cosmetiques renfermant au moins un peptide contenant au moins un cycle aromatique bloque
FR2904549B1 (fr) * 2006-08-03 2012-12-14 Sederma Sa Composition comprenant de la sarsasapogenine
CN100475189C (zh) 2006-10-17 2009-04-08 王海龙 一种化妆品组合物及其制备方法和应用
WO2008070116A2 (en) 2006-12-04 2008-06-12 Concert, Llc Topical compositions for treatment of skin conditions
US8299122B2 (en) * 2008-04-14 2012-10-30 Skinvisible Pharmaceuticals, Inc. Method for stabilizing retinoic acid, retinoic acid containing composition, and method of using a retinoic acid containing composition
FR2939799B1 (fr) 2008-12-11 2011-03-11 Sederma Sa Composition cosmetique comprenant des oligoglucuronanes acetyles.
EP2382231A2 (de) 2009-01-16 2011-11-02 Sederma Neue verbindungen, insbesondere peptide, zusammensetzungen damit und kosmetische und dermopharmazeutische verwendungen
FR2941231B1 (fr) 2009-01-16 2016-04-01 Sederma Sa Nouveaux peptides, compositions les comprenant et utilisations cosmetiques et dermo-pharmaceutiques.
FR2941232B1 (fr) 2009-01-16 2014-08-08 Sederma Sa Nouveaux peptides, compositions les comprenant et utilisations cosmetiques et dermo-pharmaceutiques.
FR2944435B1 (fr) 2009-04-17 2011-05-27 Sederma Sa Composition cosmetique comprenant de l'oridonine
FR2945939B1 (fr) 2009-05-26 2011-07-15 Sederma Sa Utilisation cosmetique du dipeptide tyr-arg pour lutter contre le relachement cutane.
WO2011042423A2 (en) 2009-10-06 2011-04-14 Basf Se Stabilization of household, body-care and food products by using benzotropolone containing plant extracts and/or related benzotropolone derivatives
US8425885B2 (en) 2009-11-09 2013-04-23 Conopco, Inc. Substituted 3-(phenoxymethyl) benzyl amines and personal care compositions
US8309064B2 (en) 2009-11-09 2012-11-13 Conopco, Inc. Skin care compositions comprising phenoxyalkyl amines
WO2012006107A2 (en) 2010-06-28 2012-01-12 Stemtide, Inc. Skin care compositions
US8293218B2 (en) 2010-07-29 2012-10-23 Conopco, Inc. Skin care compositions comprising substituted monoamines
US8476251B2 (en) 2010-07-29 2013-07-02 Conopco, Inc. Skin care compositions comprising substituted diamines
US10842728B2 (en) 2010-08-09 2020-11-24 Allele Biotechnology & Pharmaceuticals, Inc. Light-absorbing compositions and methods of use
US9205284B2 (en) 2010-08-09 2015-12-08 Allele Biotechnology & Pharmaceuticals, Inc. Light-absorbing compositions and methods of use
US9737472B2 (en) 2010-08-09 2017-08-22 Allele Biotechnology & Pharmaceuticals, Inc. Light-absorbing compositions and methods of use
US20120122936A1 (en) 2010-11-11 2012-05-17 Conopco, Inc., D/B/A Unilever Leave-on nonsolid skin conditioning compositions containing 12-[(12-hydroxyoctadecanoyl)oxy] octadecanoic acid
JP5866372B2 (ja) 2010-11-11 2016-02-17 ユニリーバー・ナームローゼ・ベンノートシヤープ １２−ヒドロキシステアリン酸を含有するリーブオン型の（ｌｅａｖｅ−ｏｎ）非固形皮膚コンディショニング組成物
US8613939B2 (en) 2010-12-15 2013-12-24 Conopco, Inc. Leave-on nonsolid skin conditioning compositions containing 12-hydroxystearic acid and ethoxylated hydrogenated castor oil
US20120214871A1 (en) 2011-02-17 2012-08-23 Conopco, Inc., D/B/A Unilever Leave-on nonsolid oil-continuous skin conditioning compositions containing 12-hydroxystearic acid
JP2014513791A (ja) 2011-02-22 2014-06-05 ザ プロクター アンド ギャンブル カンパニー スキンケア組成物用の化粧剤を同定するための方法
EP2691539B1 (de) 2011-03-31 2018-04-25 The Procter and Gamble Company Verfahren zur identifizierung und evaluierung von haut-wirkstoffen wirksam bei der behandlung von schuppen
JP2014524900A (ja) 2011-06-13 2014-09-25 ザ プロクター アンド ギャンブル カンパニー ｐＨ調整可能なゲル化剤を含むパーソナルケア組成物及び使用方法
JP2014524901A (ja) 2011-06-13 2014-09-25 ザ プロクター アンド ギャンブル カンパニー ジアミドゲル化剤を含むパーソナルケア組成物及び使用方法
CN103619308A (zh) 2011-06-20 2014-03-05 宝洁公司 包含成形研磨剂颗粒的个人护理组合物
WO2013091894A2 (en) 2011-12-21 2013-06-27 Flavin Dana Topical compositions
MX2014009923A (es) 2012-02-20 2015-08-10 Basf Se Intensificación de la acción antimicrobiana de biocidas con polimeros.
WO2013148807A1 (en) 2012-03-30 2013-10-03 The Procter & Gamble Company Method of formulating a skin-lightening composition
EP2859486A2 (de) 2012-06-06 2015-04-15 The Procter & Gamble Company Systeme und verfahren zur identifizierung kosmetischer wirkstoffe für haar-/kopfhautpflegezusammensetzungen
US9271912B2 (en) 2012-06-13 2016-03-01 The Procter & Gamble Company Personal care compositions comprising a pH tuneable gellant and methods of using
WO2014028734A1 (en) 2012-08-15 2014-02-20 The Procter & Gamble Company Human ex vivo skin model and use in methods of identifying modulators of skin inflammation
WO2014028569A1 (en) 2012-08-15 2014-02-20 The Procter & Gamble Company Systems, models and methods for identifying and evaluating skin-active agents effective for treating an array of skin disorders
WO2014139965A1 (en) 2013-03-13 2014-09-18 Unilever Plc Photoprotective compositions with tricyclodecane amides
ITMI20130995A1 (it) 2013-06-17 2014-12-18 Chemelectiva S R L Derivati dell'acido retinoico e processo per la loro preparazione
CA2933416C (en) 2013-12-10 2017-10-03 Sussex Research Laboratories Inc. Glycopeptide compositions and uses thereof
US20160000682A1 (en) 2014-07-02 2016-01-07 Geoffrey Brooks Consultants Llc Peptide-Based Compositions and Methods of Use
WO2016173817A1 (en) 2015-04-28 2016-11-03 Unilever Plc N-aralkylcarbonyl-piperazine and -homopiperazine compounds and personal care compositions comprising the same
EP3288527B1 (de) 2015-04-28 2020-02-19 Unilever PLC, a company registered in England and Wales under company no. 41424 of Aralkylcarboxamidoalkylaminverbindungen und körperpflegezusammensetzungen damit
EP3373899B1 (de) 2015-11-10 2019-09-18 Unilever Plc. Körperpflegezusammensetzungen mit cyclocarbonsäure
CA3030333A1 (en) 2016-07-27 2018-02-01 Unilever Plc Personal care compositions comprising fatty acid amide derivatives
US11083683B2 (en) 2016-10-28 2021-08-10 Coty Inc. Topical composition
EA201991003A1 (ru) 2016-12-21 2019-12-30 Юнилевер Н.В. Композиции для личной гигиены, содержащие малорастворимые соединения
EA201991185A1 (ru) 2016-12-21 2020-01-13 Юнилевер Н.В. Композиции для личной гигиены, содержащие цистин
WO2018154145A2 (en) * 2018-03-29 2018-08-30 Symrise Ag Compounds for skin improvement / treatment
GB201811312D0 (en) 2018-07-10 2018-08-29 Nuchido Ltd Compositions
EP4142677A1 (de) 2020-04-28 2023-03-08 Unilever IP Holdings B.V. Körperpflegezusammensetzungen mit wirkstoffen mit erhöhter löslichkeit
WO2022008732A1 (en) 2020-07-10 2022-01-13 Basf Se Enhancing the activity of antimicrobial preservatives

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2917523A (en) * 1959-12-15 Production of compounds of the
US2424994A (en) * 1944-06-20 1947-08-05 Research Corp Vitamin a acid and its esters and method of making them
US2576103A (en) * 1946-12-24 1951-11-27 Eastman Kodak Co Synthesis of vitamin a active compounds containing repeated isoprene units
US2951853A (en) * 1957-06-08 1960-09-06 Sumitomo Chemical Co Method for preparing polyenecarboxylic acid derivatives
BE752927A (fr) * 1969-07-04 1971-01-04 Hoffmann La Roche Utilisation de composes polyeniques
ZA71145B (en) * 1970-02-02 1971-10-27 Hoffmann La Roche Use of vitamin a-acid
DE2050658A1 (en) * 1970-10-15 1972-05-25 Badische Anilin- & Soda-Fabrik Ag, 6700 Ludwigshafen Vitamin a acid isopropyl ester - active against skin diseases
JPS5827266B2 (ja) * 1973-11-07 1983-06-08 ニツシンセイフン カブシキガイシヤ シンキナビタミン ａ サンエステル ノ セイゾウホウ
JPS5921863B2 (ja) * 1973-11-07 1984-05-22 日清製粉 （株） 新規なビタミンａ酸エステルの製造法
US3984544A (en) * 1975-02-28 1976-10-05 Schering Corporation Retinoic acid esters of steroids of the pregnane series, their use in the treatment of acne and pharmaceutical formulations useful therefor
US4055659A (en) * 1975-11-03 1977-10-25 Johnson & Johnson Retinoic acid derivatives
US4108880A (en) * 1975-11-03 1978-08-22 Johnson & Johnson Esters of retinoic acid
US4190594A (en) * 1975-11-03 1980-02-26 Johnson & Johnson Retinoic acid derivatives
US4216224A (en) * 1978-09-22 1980-08-05 Scott Eugene J Van Methods and compositions for treating psoriasis with retinoyl compounds
GB2097783B (en) * 1981-04-23 1984-12-12 Dermal Lab Ltd Imidazoles
US4529600A (en) * 1982-09-09 1985-07-16 Sri International Pentadeuterioretinoids
US4677120A (en) * 1985-07-31 1987-06-30 Molecular Design International Topical prodrugs for treatment of acne and skin diseases
DK498487A (da) * 1986-10-06 1988-04-07 Hoffmann La Roche Hidtil ukendte retinoider
ATE86611T1 (de) * 1987-06-12 1993-03-15 Molecular Design Int Topische vorstufen von arzneimitteln zur behandlung von akne und hautkrankheiten.

Also Published As

Publication number Publication date
AU2080988A (en) 1989-01-30
ATE106867T1 (de) 1994-06-15
WO1989000157A1 (en) 1989-01-12
DE3850109T2 (de) 1994-10-06
US4885311A (en) 1989-12-05
EP0366713B1 (de) 1994-06-08
AU607097B2 (en) 1991-02-21
EP0366713A1 (de) 1990-05-09
JPH03500643A (ja) 1991-02-14

Similar Documents

Publication Publication Date Title
DE3850109D1 (de) 13-trans-retinsäureester.
FR2782269B1 (fr) Composition cosmetique et/ou dermatologique contenant de l'acide salicylique ou un derive d'acide salicylique et son utilisation
NO940035D0 (no) Kolesterolester, samt anvendelse av slike estere
KR920700634A (ko) 좌창 또는 건선 피부병을 치료하는 방법 및 여기에 사용되는 조성물
RU94000061A (ru) Эфиры холестерина и ненасыщенных жирных кислот, способ лечения и фармацевтическая или косметическая композиция
NL7904144A (nl) Vetzuurpreparaten ter behandeling en voorkomen van thrombo-embolie.
FR2710527B1 (fr) Nouvelles compositions cosmétiques et dermatologiques associant céramides et acide linoléique, leur préparation.
IE871203L (en) Formulations containing unsaturated fatty acids
IT8567279A0 (it) Apparecchio per l applicazione con trollata sul tessuto umano di sostanze riducenti per realizzare microabrasioni
ATE161419T1 (de) Kosmetische zusammensetzung, die einen lipidstoff und eine hydroxy - oder ketofettsäure enthält
IT1107788B (it) Procedimento ed apparecchio per la raccolta di uva supportata su tralicci
NL7612200A (nl) Retinezuurderivaat alsmede farmaceutisch preparaat voor de behandeling van acne.
DE3468021D1 (en) Imidazol-2-yl mercapto alkanoic acids, process for producing the same and pharmaceutical preparations containing the same
ATE84716T1 (de) 4-chinolincarbonsaeure-derivate, brauchbar zur behandlung von haut- und muco-epithelialgewebekrankheiten.
IL83775A0 (en) Fumaramide derivatives and pharmaceutical compositions containing them for treating skin diseases
IT8721115A0 (it) Fitopreparato per la cura di affezioni cutanee.
DE3784738D1 (de) Topische vorstufen von arzneimitteln zur behandlung von akne und hautkrankheiten.
GR3006674T3 (de)
SE8102161L (sv) "3,7,11,15-tetrametyl-2,4,6,10,14-hexadekapentaensyra
IE811612L (en) Thiazoles
DE3851938D1 (de) Polyaromatische Ester von makroliden Antibiotika und linkosamiden Antibiotika, Verfahren zu ihrer Herstellung und diese enthaltenden pharmazeutischen und kosmetischen Zusammensetzungen.
IL89901A0 (en) Strobilurine derivatives
ES2063765T3 (es) Esteres cicloalifaticos insaturados de antibioticos macrolidicos y lincosamidicos, su procedimiento de preparacion y composiciones farmaceuticas y cosmeticas que los contienen.
EP0301449A3 (en) Enantiomers of propafenone-containing therapeutic agents
ATE113292T1 (de) Aromatische ester von makroliden antibiotika und linkosamiden antibiotika, verfahren zu ihrer herstellung und die sie enthaltenden pharmazeutischen und kosmetischen zusammensetzungen.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee